Heron Therapeutics reported 2.41M in Interest Expense on Debt for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
ALKERMES ALKS:US 2.37M 19K
Alnylam Pharmaceuticals ALNY:US $ 42.61M 247K
Emergent Biosolutions EBS:US $ 7.8M 0.4M
Esperion Therapeutics ESPR:US $ 14.27M 204K
Immunogen IMGN:US $ 1.08M 0.17M
Insmed INSM:US $ 3.36M 66K
JAZZ PHA JAZZ:US $ 63.89M 7M
Nektar Therapeutics NKTR:US $ 7.23M 0.3M
Neurocrine Biosciences NBIX:US $ 2.2M 0.4M
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Regeneron Pharmaceuticals REGN:US $ 13.1M 0.5M
Surmodics SRDX:US $ 0.14M 0.02M
Teva Pharmaceutical Industries TEVA:US $ 225M 13M
Veracyte VCYT:US $ 0.07M 0.01M
Vertex Pharmaceuticals VRTX:US $ 14.6M 0.3M